CIK: 1216074 - Address: 555 Heritage Drive, Suite 200, Jupiter, FL 33458
24 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret2134-214114886999489
P%wins6733671006710072
S%ret214-2-3-6-6-16-12-7
S%wins100751007510010092

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

11/17/21 17:06
11/16/21
LGNDLigand Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsLamattina John LCADM.d15632.30052425D
11/17/21 17:06
11/16/21
LGNDLigand Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsLamattina John LCADS.d-783161.860-5-1625D
5/26/21 21:26
5/24/21
IMNMImmunome Inc.DEHealthDrugPharmaceutical PreparationsLamattina John LPADP10118.57051252D
8/5/19 19:00
8/1/19
LGNDLigand Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsLamattina John LCADM.d8132.30031224D
9/5/18 19:59
9/4/18
LGNDLigand Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsLamattina John LCADM.d4212.53031821D
9/5/18 19:59
9/4/18
LGNDLigand Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsLamattina John LCADS.d-850254.960-3-1321D
6/4/18 19:01
6/4/18
LGNDLigand Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsLamattina John LCADM.d5012.53042421D
6/4/18 19:01
6/4/18
LGNDLigand Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsLamattina John LCADS.d-778194.510-4-1621D
3/6/18 18:36
3/5/18
LGNDLigand Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsLamattina John LCADM.d3410.12031921D
3/6/18 18:36
3/5/18
LGNDLigand Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsLamattina John LCADS.d-537160.900-3-1421D
11/17/17 19:19
11/17/17
LGNDLigand Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsLamattina John LCADM.d4010.12042421D
11/17/17 19:19
11/17/17
LGNDLigand Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsLamattina John LCADS.d-559139.790-4-1621D
3/20/14 18:40
3/18/14
LGNDLigand Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsLamattina John LCADM.d458.972753121D3772316550369113-6-12-17-15-33-2
3/20/14 18:40
3/18/14
LGNDLigand Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsLamattina John LCADS.d-39478.8327-5-1921D3772316550369113-6-12-17-15-33-2
8/11/11 17:05
8/10/11
HGSIHuman Genome Sciences IncDEHealthBioPrdBiological Products, (No DiagLamattina John LMDDM.d252.0933123745D-6-44-40-46-41-36-24-621-26-38-36
3/14/11 16:12
3/11/11
LGNDLigand Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsLamattina John LCADP989.8011060012D-43-621714-1-10-8-2-3235765
3/16/09 17:13
3/13/09
HGSIHuman Genome Sciences IncDEHealthDiagnIn Vitro & In Vivo DiagnosticLamattina John LMDDP70.7194410503041150308999999
11/13/08 10:02
11/12/08
HGSIHuman Genome Sciences IncDEHealthDiagnIn Vitro & In Vivo DiagnosticLamattina John LMADP442.19520New20D-84-80-68-75-65-39-41-3211-15-932-7999
6/18/07 16:38
6/15/07
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsLamattina John LNYOSVPS.d-95526.4833-36-7449D01977-1-4-110-3-1-6-8-28
2/8/07 15:40
2/7/07
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsLamattina John LNYOSVPM.d25318.3533143479D1811523-13000-44-5-10
2/8/07 15:40
2/7/07
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsLamattina John LNYOSVPS.d-36626.5433-14-3479D1811523-13000-44-5-10
5/10/05 10:50
5/6/05
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsLamattina John LNYOSVPS-1,10727.8133-40-9396D-9-21-2139251-120-6-19-6
6/22/04 10:15
6/18/04
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsLamattina John LNYOSVPM.d355.713362395D2134-30-20-1-3-9-11-26-16
3/10/04 18:53
3/9/04
TMOThermo Electron CorpDEElectrLabEqMeasuring & Controlling DevicLamattina John LMADM.d1918.86171503D34582019000-2-1-268-40

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact